Nevro (NYSE: NVRO) stock lost more than a fifth of its value this morning — a day after the maker of spinal cord stimulation devices greatly reduced its full-year guidance. Redwood City, California–based Nevro now expects full-year 2023 revenue of roughly $410–415 million, an increase of 1–2% over 2022. The previous guidance was for $445–455 […]
Pain Management
Tivic Health reduces workforce as it may face Nasdaq delisting
Tivic Health (Nasdaq:TIVC) CEO Jennifer Ernst issued a letter to investors updating them on the current situation at the bioelectronic medicine developer. Ernst’s letter included the announcement that the company took several measures to fortify its position. That includes a reduction in force and internal restructuring. The company did not disclose further details about the […]
U.S. military to test Bexson Biomedical ketamine delivery device
Bexson Biomedical announced that the U.S. military intends to field-test its Akeso wearable ketamine delivery device. Akeso, a ruggedized version of Bexson Biomedical’s wearable infusion device, utilizes Sevalent technology. Sevalent, Bexson’s proprietary formulation platform can work with small molecules across a broad range of drug classes. It enables subcutaneous intravenous (IV) therapy delivery. Bexson management […]
NeuroMetrix is expanding its salesforce
NeuroMetrix (Nasdaq: NURO) second-quarter results took a hit from challenges related to reimbursement changes at CMS, but Quell Fibromyalgia saw positive trends. The Woburn, Massachusetts–based company’s Quell neuromodulation device won FDA de novo nod to treat fibromyalgia in May 2022. The company had 123 unique prescribers for the fibromyalgia therapy in Q2, versus 92 in […]
NeuroOne prices $5.25M public offering
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it priced an underwritten registered public offering. Eden Prairie, Minnesota-based NeuroOne’s offering includes 5.25 million shares of common stock priced at $1 per share. All shares included in the offering will be sold by the company. NeuroOne also granted the underwriter a 30-day option to purchase up to […]
4-year data backs Relievant Medsystems’ Intracept ablation procedure
Relievant Medsystems announced four-year pooled data from two prospective clinical trials that support the use of its Intracept procedure. Intracept — a minimally invasive, FDA-cleared, same-day, outpatient procedure — treats chronic vertebrogenic low back pain. The procedure utilizes targeted radiofrequency energy to ablate the basivertebral nerve (BVN). This stops the nerve from transmitting pain signals […]
Tivic Health prices $2.1M offering
Tivic Health (Nasdaq:TIVC) announced today that it priced its previously announced public offering of common stock at $2.1 million. News of this offering follows the pricing of a $1.8 million offering of common stock last week. San Francisco-based Tivic’s offer includes 51.25 million shares of common stock priced at 4¢ per share. The company expects […]
Relievant Medsystems unveils new tools for its ablation system
Relievant Medsystems announced today that it launched its next-generation access instruments for the Intracept procedure. Intracept — a minimally invasive, FDA-cleared, same-day, outpatient procedure — treats chronic vertebrogenic low back pain. It uses targeted radiofrequency energy to ablate the basivertebral nerve (BVN). This stops the nerve it from transmitting pain signals to the brain. The […]
Tivic Health prices $1.8M common stock offering
Tivic Health Systems (Nasdaq:TIVC) announced today that it priced an offering of its common stock worth approximately $1.8 million. San Francisco-based Tivic priced the offering of 32.5 million shares of its common stock at $0.055 per share. The company intends to use the net proceeds for working capital and general corporate purposes. Tivic said it […]
Presidio Medical raises $72M for ultra-low frequency neuromod tech
Presidio Medical announced that it closed a $72 million Series C funding round to support its ultra-low frequency (ULF) neuromodulation platform. Deerfield Management led the round along with existing investors Invus Opportunities and Action Potential Venture Capital. ShangBay Capital joined in the funding as well. David Neustaedter, venture partner at Deerfield, joined Presidio’s board in […]
Relievant Medsystems reports positive data for nerve ablation procedure
Relievant Medsystems announced today that three-year data from two clinical trials further validate its Intracept procedure. Intracept, a minimally invasive, FDA-cleared, same-day, outpatient procedure, treats chronic vertebrogenic low back pain. It uses targeted radiofrequency energy to ablate the basivertebral nerve (BVN), stopping it from transmitting pain signals to the brain. The procedure takes approximately one […]